Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Opportunities for accelerating innovation and mitigating risk at the nexus of IP and R&D

Sponsored by

Logo 22.07.22.png
Vector circle tech with light blue and lamp bulb on technology b

The CAS IP Research Team analyse how organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation

The transformation of IP management within commercial companies is driving the adoption of new practices and technologies to more closely align IP objectives with growth strategies, unlock greater portfolio value, and support strategic decision-making across enterprises.

This research white paper from CAS explores this transformation at the nexus of IP and research and development (R&D), where organisations are applying IP insights to accelerate scientific breakthroughs and identify potential risks to commercialisation earlier in the product lifecycle.

Missing critical IP information during R&D can lead to misallocated resources, potential patent entanglements downstream, and delays in commercialisation. The white paper provides valuable insights for R&D and IP managers about these critical topics:

  • Top IP management goals over the next 12 months;

  • Role and use of IP information across organisations;

  • Challenges in using IP information; 

  • State of IP information access and investments; and 

  • Resolving IP information gaps 

Click here to access CAS’s white paper – “Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D”

Click here to access CAS’s content hub on Managing IP

more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article